Humana Inc (HUM · NYSE)

Humana shares jumped 11.6% in a single day to $431.87, putting the stock at its 52-week high on volume 3.3x its 20-day average, after beating Q2 EPS estimates by 22.3% ($7.61 vs. $6.22) — its fourth consecutive beat. Revenue grew 26.2% year over year to $40.87B in the quarter, though profitability remains thin at a 0.9% profit margin and 3.5% operating margin, and the company posted negative operating cash flow of $426.0M with free cash flow of $558.0M for the period. Leverage sits at 4.0x debt/EBITDA against $6.89B in cash, while the stock trades at a 40.82 P/E, roughly 45.8% above its 200-day moving average, and well above the analyst target of $452.87.